 Home > Active Ingredient News > Antitumor Therapy > Nat Aging: Targeting the epigenetic enzyme KDM4 to help treat aging and tumors

Nat Aging: Targeting the epigenetic enzyme KDM4 to help treat aging and tumors

 Last Update: 2021-06-08
 Source: Internet
 Author: User

Tags

autoimmune cancer types

advanced pavement group

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Existing studies have shown that aging is a self-control mechanism that limits the excessive proliferation of cells and prevents the development of tumors by implementing stable, long-lasting, and usually irreversible growth arrest.

Some evidence suggests that SASP is essential for tissue repair, wound healing, embryonic development, and immune surveillance to remove senescent cells .

immunity

Although the limited therapeutic effect depends on the specific environment, the negative impact of SASP in advanced cancer far exceeds its beneficial contribution, and ultimately accelerates the development of the disease.

Recently, researchers discovered that histone H3-specific demethylase KDM4 is expressed when human stromal cells age.

In clinical oncology, the up-regulation of KDM4 and the decrease of H3K9/H3K36 methylation are associated with poor survival of prostate cancer patients after chemotherapy.

Epigenetic changes in the lysine sites of histone H3 during cell senescence

Epigenetic changes in histone H3 lysine sites during cell senescence .

Selective targeting of KDM4 can inhibit SASP of senescent stromal cells Selective targeting of KDM4 can inhibit SASP of senescent stromal cells

This study supports the dynamic changes of H3K9/H3K36 methylation during aging, determines an abnormally tolerable chromatin state, and unveils KDM4 as a key regulator of SASP.

In conclusion, the study uses KDM4 as the target and proposes a new therapeutic approach to manipulate cellular senescence and limit its contribution to age-related diseases including cancer .

With KDM4 as the target, a new therapeutic approach is proposed to manipulate cell senescence and limit its contribution to age-related diseases including cancer.

Original source:

Boyi Zhanget al.

Boyi Zhang et al.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.